NNOX - Nano-X Imaging Receives FDA Clearance for X-Ray Device
Nano-X Imaging (NASDAQ: NNOX) announced on Friday that its X-ray device received clearance from the Food and Drug Administration. The Israeli company, which just went public on the Nasdaq last year, expects to file for two more clearances from the FDA later this year.
"Obtaining 501(K) clearance from the FDA for our single-source Nanox.ARC digital X-ray is a significant step forward along our U.S. regulatory pathway," CEO Ran Poliakine said in a press release. "We remain on track to commence shipments in the fourth quarter of 2021 and the first quarter of 2022 with the goal of finalizing deployment of the initial 15,000 Nanox.ARC systems by the end of 2024."
Image source: Nano-X Imaging.
For further details see:
Nano-X Imaging Receives FDA Clearance for X-Ray Device